Business Wire

Mary Kay Inc. Advocates for Advancing Women’s Economic Empowerment and Gender Equality Through Series of Milestone Commitments & Partnerships Around the World

20.7.2021 16:03:00 EEST | Business Wire | Press release

Share

Mary Kay Inc., a global advocate for women’s empowerment and entrepreneurship, has furthered its commitment to advancing gender parity by releasing a position paper welcoming the European Commission’s Gender Equality Strategy for 2020 – 2025 and by joining the Generation Equality Forum Global Action Coalitions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005347/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

This month, Mary Kay also joined the “Drivers of change” Program at the Generation Equality Forum in Paris, France (June 30 - July 2). (Graphic: Mary Kay Inc.)

The position paper, which can be accessed here, echoes the strategy of the European Union on gender equality. According to the European Union: “The Strategy presents policy objectives and actions to make significant progress by 2025 towards a gender-equal Europe. The goal is a Union where women and men, girls and boys, in all their diversity, are free to pursue their chosen path in life, have equal opportunities to thrive, and can equally participate in and lead our European society.”

“Discriminatory laws, gender bias and stereotyping, violence against women and girls - these are all global issues and must be tackled in partnership with the public and private sectors and civil society organizations across the world,” said Julia Simon, Chief Legal & Diversity Officer at Mary Kay. “Achieving gender equality is critical to the survival of the planet and the rebuilding of more sustainable and thriving economies and societies.”

This month, Mary Kay also joined the “Drivers of change” Program at the Generation Equality Forum in Paris, France (June 30 - July 2). 26 years after the Beijing Declaration, the Generation Equality Forum, convened by UN Women and co-hosted by the governments of Mexico and France, was the “most critical moment in a generation to invest in gender equality and accelerate momentum for women’s safety, leadership and economic opportunity1.”

Julia Simon participated to a panel titled “Building a Transformative Strategy for Gender-Responsive Procurement,” aiming at creating awareness of the disproportionately complex and interconnected barriers on women’s entrepreneurship and promoting gender-responsive procurement. Globally, 1 in 3 businesses are owned by women2, yet women win only 1% of the procurement spend of governments and large corporations3. Speakers shared insights and concrete advice substantiated by their own journey on how to implement a GRP strategy.

At the Paris Forum, Mary Kay also joined four of the Generation Equality Action Coalitions through policy, programmatic, and advocacy commitments: Economic Justice and Rights; Feminist Action for Climate Justice; Gender-based Violence and Innovation and Technology. 50,000 people virtually engaged in the Forum which gathered 1,000 commitment-makers, recorded $40 billion of investments for gender equality in support of a 5-year plan to act for equal across 6 areas of action.

These engagements are the latest of a series of Mary Kay’s advocacy efforts in support of women’s economic empowerment and gender equality at high level meetings around the world alongside its UN partners and local strategic partners.

  • On March 16, 2021, Deborah Gibbins, Mary Kay’s COO, joined the UN Global Compact Target Gender Equality meeting to discuss how Mary Kay empowers women entrepreneurs in nearly 40 countries. Gibbins highlighted the data freshly released by the World Bank4 revealing that, on average across the world, women have three quarters the legal rights of men. She challenged companies to take a stand against legal discriminations and advocate for reforms to close the gaps so that women can achieve their full potential. The event brought together over 5,000 people from the business sector, the United Nations, member states, and civil society organizations from over 100 countries, with 75% of the participants representing the private sector.
  • On March 24, 2021, on the sidelines of the Commission on the Status of Women (CSW65), Gibbins participated in a panel hosted by the Women’s Empowerment Accelerator (WEA) titled “Women Leading Economic Recovery Through Entrepreneurship” where she highlighted the need for public-private sector partnerships to help shape an enabling ecosystem for women entrepreneurs. Incepted by Mary Kay in collaboration with 5 UN agencies, The Women’s Entrepreneurship Accelerator was featured as an example of the unique impact of multi-partnership to accelerate change.
  • On March 26-April 4, Edita Szabóová, General Manager of Mary Kay Czech Republic and Slovakia, shared remarks at the Equal Pay Day Conference where she stressed the importance of “women supporting women,” and highlighted the work of Mary Kay in nurturing women entrepreneurs through training, leadership, and mentorship. “When women come together, we can achieve extraordinary things for the benefit of women and humanity at large. Because we know that if we lift one, we lift all. At its core, Mary Kay develops and trains entrepreneurs, who, in turn, get to build their own businesses and write their own stories and legacy for their daughters,” said Szabóová.
  • On June 15-16, 2021, at the UN Global Compact Leaders Summit, Gibbins spoke at the “Women In Sustainability: Innovating In A Man’s World” main stage session advocating for women entrepreneurs as the role models needed for the economy and society. She also emphasized the critical mission of the Women’s Entrepreneurship Accelerator incepted by Mary Kay together with 5 UN agency partners: UN Women, the UN Global Compact, International Trade Centre, the International Labour Organization and the UN Development Programme. The Accelerator has committed to educating and empowering 5 million women entrepreneurs over the next 10 years. “Women entrepreneurship will play a key role in the successful pandemic recovery. This is why the mission of the Women’s Entrepreneurship Accelerator is so timely. And, this is why women entrepreneurs need a framework of this magnitude,” said Gibbins. The annual Summit convened virtually more than 25,000 leaders from business, government, the UN, and civil society, to take stock of the state of progress and to drive collective action towards alleviating climate crisis, global pandemic, economic disparities, and social inequalities.
  • On July 6, in Ekaterinburg, Mary Kay joined the International Industrial Trade Fair INNOPROM-2021 the main industrial, trade and export platform in Russia. Guest speaker at a panel hosted by UN Women titled “UN Women Programs for the Promotion and Development of Gender-Based Entrepreneurship,” Mary Kay highlighted the critical importance of gender-responsive procurement strategies and emphasized that the pandemic also brings a unique opportunity to advance action and to support women’s businesses around the world.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company almost 58 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at www.marykay.com

1 https://forum.generationequality.org/home
2 World Bank (2020). Enterprise Surveys, World Bank Gender Data Portal cited by World Bank Blogs (2020) Women entrepreneurs needed – stat!
3 Vazquez and Sherman (2014). Cited by UN Women (2017) The Power of Procurement: How to source from women-owned businesses.
4 Women, Business and the Law, 2021. A report conducted in 190 countries.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
Marykay.com/newsroom
(+1) 972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye